Overexpression of EGFR is implicated in all aggressive cancers of epithelial origin including squamous cell head & neck (90 – 100%) [1], glioma (90 – 100%) [2], non-small cell lung (75 – 90%), colorectal (80 – 85%) [3], breast (20 – 30%) [4] and cervical [5] cancers. This evidence concerns the gene EGFR and cancer.